Scarica l'app Stockscreener
13.12
0.85%
0.11
Dopo l'orario di chiusura:
13.12
Precedente Chiudi:
$13.01
Aprire:
$12.73
Volume 24 ore:
672.87K
Relative Volume:
1.18
Capitalizzazione di mercato:
$579.45M
Reddito:
$200.93M
Utile/perdita netta:
$-18.91M
Rapporto P/E:
-29.69
EPS:
-0.4419
Flusso di cassa netto:
$-9.09M
1 W Prestazione:
+2.18%
1M Prestazione:
-16.43%
6M Prestazione:
-8.32%
1 anno Prestazione:
-8.64%
Intervallo 1D:
$12.37
$13.17
Intervallo di 1 settimana:
$12.15
$13.17
Portata 52W:
$12.15
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Nome
Si Bone Inc
Settore
Industria
Telefono
(408) 207-0700
Indirizzo
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
13.12 | 579.45M | 200.93M | -18.91M | -9.09M | -0.4419 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | TD Cowen | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-04-07 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-06-08 | Iniziato | Citigroup | Buy |
| 2021-03-09 | Reiterato | Needham | Buy |
| 2020-12-16 | Reiterato | Needham | Buy |
| 2020-08-04 | Reiterato | Needham | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-05-05 | Reiterato | Needham | Buy |
| 2020-02-19 | Iniziato | Needham | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-12-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-11-12 | Iniziato | BofA/Merrill | Buy |
| 2018-11-12 | Iniziato | Canaccord Genuity | Buy |
| 2018-11-12 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-11-12 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Si Bone Inc Borsa (SIBN) Ultime notizie
Si-Bone CFO Maheshwari sells $42,707 in stock By Investing.com - Investing.com South Africa
SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 1,799 Shares - MarketBeat
SiBone (NASDAQ:SIBN) SVP Sells $17,168.10 in Stock - MarketBeat
Si-Bone CFO Maheshwari sells $42,707 in stock - Investing.com
Tax-driven share sale by SI-BONE (SIBN) chief legal officer - Stock Titan
SI-BONE Inc stock: Why this medtech innovator could reshape spine surgery - AD HOC NEWS
Will SI BONE Inc benefit from rising consumer demand2026 Historical Comparison & Fast Entry and Exit Trade Plans - baoquankhu1.vn
SI-BONE Inc Stock: Innovating Sacroiliac Joint Fusion in a Competitive Medtech Landscape - AD HOC NEWS
SiBone (NASDAQ:SIBN) Sees Large Growth in Short Interest - MarketBeat
SI-BONE raises 2025 revenue guidance to $195M-$198M with accelerated cash flow milestones - MSN
SiBone (NASDAQ:SIBN) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Vanguard files 13G/A showing 0 shares in SI-BONE (SIBN) - stocktitan.net
SiBone (NASDAQ:SIBN) Sets New 12-Month LowWhat's Next? - MarketBeat
Aug PostEarnings: What is the next catalyst for SI BONE Inc2026 Big Picture & Real-Time Buy Signal Notifications - baoquankhu1.vn
Piper Sandler reiterates SI-BONE stock rating on growth outlook By Investing.com - Investing.com Australia
Piper Sandler reiterates SI-BONE stock rating on growth outlook - Investing.com
Jim Cramer on SI-BONE, Inc.: "We're not going to buy the money losers" - MSN
(SIBN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Stop Loss: Is SI BONE Inc stock showing strong momentumQuarterly Growth Report & Safe Entry Momentum Tips - baoquankhu1.vn
S P Trends: Is SI BONE Inc stock showing strong momentumQuarterly Market Review & Real-Time Volume Triggers - baoquankhu1.vn
SI-BONE outlines 14%-16% revenue growth for 2026 with new product launches and Smith & Nephew partnership - MSN
Granahan Investment Management LLC Sells 224,678 Shares of SiBone $SIBN - MarketBeat
SiBone $SIBN Shares Purchased by First Light Asset Management LLC - MarketBeat
Divisadero Street Capital Management LP Trims Holdings in SiBone $SIBN - MarketBeat
Nishimura Mika, Si-Bone director, sells $56k in SIBN stock - Investing.com
SiBone (NASDAQ:SIBN) Director Mika Nishimura Sells 4,100 Shares - MarketBeat
Insider Sell: Mika Nishimura Sells 4,100 Shares of SI-BONE Inc (SIBN) - GuruFocus
[Form 4] SI-BONE, Inc. Insider Trading Activity - Stock Titan
Jim Cramer on SI-BONE, Inc.: “We’re Not Going to Buy the Money Losers” - Insider Monkey
[144] SI-BONE, Inc. SEC Filing - Stock Titan
SiBone (NASDAQ:SIBN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Liquidity Mapping Around (SIBN) Price Events - Stock Traders Daily
Jim Cramer on SI-BONE: "This is a great, great speculation" - MSN
American Century Companies Inc. Acquires 521,683 Shares of SiBone $SIBN - MarketBeat
Earnings Recap: Can SI BONE Inc disrupt its industryGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
Will SI BONE Inc. stock deliver strong dividend growthJuly 2025 Chart Watch & High Win Rate Trade Tips - Naître et grandir
SIBN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
First Eagle Investment Management LLC Has $7.13 Million Stock Position in SiBone $SIBN - MarketBeat
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026 - GlobeNewswire Inc.
SIBN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Si-Bone at TD Cowen Health Care Conference: Strategic Growth Plans - Investing.com
SIBN PE Ratio & Valuation, Is SIBN Overvalued - Intellectia AI
SIBN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SIBN SEC FilingsSi-Bone 10-K, 10-Q, 8-K Forms - Stock Titan
Why (SIBN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SI-BONE, Inc. (SIBN) Stock Analysis: Strong Buy Ratings Signal 57.73% Potential Upside - DirectorsTalk Interviews
Smith+Nephew signs distribution agreement with SI-BONE - MedTech Intelligence
Aug Technicals: What is the next catalyst for SI BONE Inc2025 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partne - The National Law Review
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partnership to Expand Access For Veterans & Wounded Warriors - EIN Presswire
Si Bone Inc Azioni (SIBN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):